Prostate Cancer Treatment Seen Drawing Medivation Bids

Prostate Cancer Treatment Seen Drawing Medivation Bids

Haruyoshi Yamaguchi/Bloomberg

Astellas Pharma Inc., Medivation’s partner on the drug, may want to buy out the $3.3 billion company to avoid splitting the profit, ThinkEquity LLC said.